Correction to: Leukemia; doi:10.1038/leu.2012.119; advance online publication, 3 May 2012
Since the publication of this article, the authors have noticed an error in Figure 4a, specifically that the structures of the methyl-pomalidomide enantiomers were missing a carbonyl group.
The error has now been rectified, and the correct article (with the correct figure 4) appears in this issue. The html and online pdf versions have also been rectified, and now carry the correct paper.
The authors would like to apologise for any inconvenience this may have caused.
Additional information
The online version of the original article can be found at 10.1038/leu.2012.119
Rights and permissions
About this article
Cite this article
Lopez-Girona, A., Mendy, D., Ito, T. et al. Erratum: Cereblon is a direct protein target for immunomodulatory and antiproliferative activities of lenalidomide and pomalidomide. Leukemia 26, 2445 (2012). https://doi.org/10.1038/leu.2012.235
Published:
Issue Date:
DOI: https://doi.org/10.1038/leu.2012.235
